ATC code M01
ATC code M01
Jump to navigation
Jump to search
ATC codes |
---|
M Musculo-skeletal system |
M01 Anti-inflammatory and antirheumatic products |
M02 Topical products for joint and muscular pain |
M03 Muscle relaxants |
M04 Antigout preparations |
M05 Drugs for treatment of bone diseases |
M09 Other drugs for disorders of the musculo-skeletal system |
ATC code M01 Anti-inflammatory and antirheumatic products is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup M01 is part of the anatomical group M Musculo-skeletal system.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QM01.[2] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
Contents
1 M01A Anti-inflammatory and antirheumatic products, non-steroids
1.1 M01AA Butylpyrazolidines
1.2 M01AB Acetic acid derivatives and related substances
1.3 M01AC Oxicams
1.4 M01AE Propionic acid derivatives
1.5 M01AG Fenamates
1.6 M01AH Coxibs
1.7 M01AX Other anti-inflammatory and antirheumatic agents, non-steroids
2 M01B Anti-inflammatory/antirheumatic agents in combination
2.1 M01BA Anti-inflammatory/antirheumatic agents in combination with corticosteroids
2.2 M01BX Other anti-inflammatory/antirheumatic agents in combination with other drugs
3 M01C Specific antirheumatic agents
3.1 M01CA Quinolines
3.2 M01CB Gold preparations
3.3 M01CC Penicillamine and similar agents
3.4 M01CX Other specific antirheumatic agents
4 References
M01A Anti-inflammatory and antirheumatic products, non-steroids[edit]
M01AA Butylpyrazolidines[edit]
- M01AA01 Phenylbutazone
- M01AA02 Mofebutazone
- M01AA03 Oxyphenbutazone
- M01AA05 Clofezone
- M01AA06 Kebuzone
- QM01AA90 Suxibuzone
- QM01AA99 Combinations
[edit]
- M01AB01 Indometacin
- M01AB02 Sulindac
- M01AB03 Tolmetin
- M01AB04 Zomepirac
- M01AB05 Diclofenac
- M01AB06 Alclofenac
- M01AB07 Bumadizone
- M01AB08 Etodolac
- M01AB09 Lonazolac
- M01AB10 Fentiazac
- M01AB11 Acemetacin
- M01AB12 Difenpiramide
- M01AB13 Oxametacin
- M01AB14 Proglumetacin
- M01AB15 Ketorolac
- M01AB16 Aceclofenac
- M01AB17 Bufexamac
- M01AB51 Indometacin, combinations
- M01AB55 Diclofenac, combinations
M01AC Oxicams[edit]
- M01AC01 Piroxicam
- M01AC02 Tenoxicam
- M01AC04 Droxicam
- M01AC05 Lornoxicam
- M01AC06 Meloxicam
- M01AC56 Meloxicam, combinations
M01AE Propionic acid derivatives[edit]
- M01AE01 Ibuprofen
- M01AE02 Naproxen
- M01AE03 Ketoprofen
- M01AE04 Fenoprofen
- M01AE05 Fenbufen
- M01AE06 Benoxaprofen
- M01AE07 Suprofen
- M01AE08 Pirprofen
- M01AE09 Flurbiprofen
- M01AE10 Indoprofen
- M01AE11 Tiaprofenic acid
- M01AE12 Oxaprozin
- M01AE13 Ibuproxam
- M01AE14 Dexibuprofen
- M01AE15 Flunoxaprofen
- M01AE16 Alminoprofen
- M01AE17 Dexketoprofen
- M01AE18 Naproxcinod
- M01AE51 Ibuprofen, combinations
- M01AE52 Naproxen and esomeprazole
- M01AE53 Ketoprofen, combinations
- M01AE56 Naproxen and misoprostol
- QM01AE90 Vedaprofen
- QM01AE91 Carprofen
- QM01AE92 Tepoxalin
M01AG Fenamates[edit]
- M01AG01 Mefenamic acid
- M01AG02 Tolfenamic acid
- M01AG03 Flufenamic acid
- M01AG04 Meclofenamic acid
- QM01AG90 Flunixin
M01AH Coxibs[edit]
- M01AH01 Celecoxib
- M01AH02 Rofecoxib
- M01AH03 Valdecoxib
- M01AH04 Parecoxib
- M01AH05 Etoricoxib
- M01AH06 Lumiracoxib
- M01AH07 Polmacoxib
- QM01AH90 Firocoxib
- QM01AH91 Robenacoxib
- QM01AH92 Mavacoxib
- QM01AH93 Cimicoxib
- QM01AH94 Deracoxib
M01AX Other anti-inflammatory and antirheumatic agents, non-steroids[edit]
- M01AX01 Nabumetone
- M01AX02 Niflumic acid
- M01AX04 Azapropazone
- M01AX05 Glucosamine
- M01AX07 Benzydamine
- M01AX12 Glucosaminoglycan polysulfate
- M01AX13 Proquazone
- M01AX14 Orgotein
- M01AX17 Nimesulide
- M01AX18 Feprazone
- M01AX21 Diacerein
- M01AX22 Morniflumate
- M01AX23 Tenidap
- M01AX24 Oxaceprol
- M01AX25 Chondroitin sulfate
- M01AX26 Avocado and soybean oil, unsaponifiables
- QM01AX52 Niflumic acid, combinations
- M01AX68 Feprazone, combinations
- QM01AX90 Pentosan polysulfate
- QM01AX91 Aminopropionitrile
- QM01AX92 Grapiprant
- QM01AX99 Combinations
M01B Anti-inflammatory/antirheumatic agents in combination[edit]
M01BA Anti-inflammatory/antirheumatic agents in combination with corticosteroids[edit]
- M01BA01 Phenylbutazone and corticosteroids
- M01BA02 Dipyrocetyl and corticosteroids
- M01BA03 Acetylsalicylic acid and corticosteroids
- QM01BA99 Combinations
M01BX Other anti-inflammatory/antirheumatic agents in combination with other drugs[edit]
M01C Specific antirheumatic agents[edit]
M01CA Quinolines[edit]
- M01CA03 Oxycinchophen
M01CB Gold preparations[edit]
- M01CB01 Sodium aurothiomalate
- M01CB02 Sodium aurothiosulfate
- M01CB03 Auranofin
- M01CB04 Aurothioglucose
- M01CB05 Aurotioprol
M01CC Penicillamine and similar agents[edit]
- M01CC01 Penicillamine
- M01CC02 Bucillamine
M01CX Other specific antirheumatic agents[edit]
References[edit]
^ "ATC/DDD Index 2018: code M01". WHO Collaborating Centre for Drug Statistics Methodology..mw-parser-output cite.citationfont-style:inherit.mw-parser-output qquotes:"""""""'""'".mw-parser-output code.cs1-codecolor:inherit;background:inherit;border:inherit;padding:inherit.mw-parser-output .cs1-lock-free abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-lock-limited a,.mw-parser-output .cs1-lock-registration abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-lock-subscription abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registrationcolor:#555.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration spanborder-bottom:1px dotted;cursor:help.mw-parser-output .cs1-hidden-errordisplay:none;font-size:100%.mw-parser-output .cs1-visible-errorfont-size:100%.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-formatfont-size:95%.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-leftpadding-left:0.2em.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-rightpadding-right:0.2em
^ "ATCvet Index 2018: code QM01". WHO Collaborating Centre for Drug Statistics Methodology.
Categories:
- ATC codes
- Anti-inflammatory agents
(window.RLQ=window.RLQ||).push(function()mw.config.set("wgPageParseReport":"limitreport":"cputime":"0.308","walltime":"0.382","ppvisitednodes":"value":905,"limit":1000000,"ppgeneratednodes":"value":0,"limit":1500000,"postexpandincludesize":"value":46086,"limit":2097152,"templateargumentsize":"value":655,"limit":2097152,"expansiondepth":"value":11,"limit":40,"expensivefunctioncount":"value":0,"limit":500,"unstrip-depth":"value":1,"limit":20,"unstrip-size":"value":4881,"limit":5000000,"entityaccesscount":"value":0,"limit":400,"timingprofile":["100.00% 247.521 1 -total"," 67.73% 167.652 1 Template:ATC_codes_lead"," 39.87% 98.679 2 Template:Cite_web"," 27.93% 69.125 3 Template:Navbox"," 23.81% 58.938 1 Template:ATC_code_M"," 21.73% 53.792 1 Template:ATC_codes_short"," 12.10% 29.950 16 Template:Anchor"," 7.01% 17.359 1 Template:Reflist"," 6.51% 16.108 1 Template:Anti-inflammatory_and_antirheumatic_products"," 5.75% 14.222 1 Template:Antirheumatic_products"],"scribunto":"limitreport-timeusage":"value":"0.106","limit":"10.000","limitreport-memusage":"value":2505933,"limit":52428800,"cachereport":"origin":"mw1242","timestamp":"20181209184343","ttl":1900800,"transientcontent":false););"@context":"https://schema.org","@type":"Article","name":"ATC code M01","url":"https://en.wikipedia.org/wiki/ATC_code_M01","sameAs":"http://www.wikidata.org/entity/Q434135","mainEntity":"http://www.wikidata.org/entity/Q434135","author":"@type":"Organization","name":"Contributors to Wikimedia projects","publisher":"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":"@type":"ImageObject","url":"https://www.wikimedia.org/static/images/wmf-hor-googpub.png","datePublished":"2004-07-25T15:36:11Z","dateModified":"2017-11-28T01:43:48Z","headline":"therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System: Anti-inflammatory and antirheumatic products"(window.RLQ=window.RLQ||).push(function()mw.config.set("wgBackendResponseTime":112,"wgHostname":"mw1322"););